When investors are paying such high price tags for a stock, expectations are high, and any kind of miss can result in a steep ...

"Given the fact that there are states, counties, cities, school districts, pension funds, and other plaintiffs from all over ...

FOIA requests to the federal government often are signals. They can be an important early warning of bad publicity, litigation to come, or uncertainties to be hedged and gamed out. When the flow of ...

Eli Lilly markets tirzepatide through two brand names: Mounjaro and Zepbound. The former has been approved by the FDA to combat type 2 diabetes, while the latter is used for weight loss.

Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this. On rare occasions, our expert team of analysts issues a “Double Down” stock ...

Mumbai: Global pharma major Lupin Limited has announced the acquisition of Huminsulin in India from Eli Lilly and Company to further enhance its diabetes portfolio. Lupin has been marketing the ...

Global pharma major Lupin Limited on Monday announced the acquisition of Huminsulin in India from Eli Lilly and Company (Lilly) to further enhance its diabetes portfolio. According to the company ...

Shares of Lupin hit a new high of Rs 2,361.95, gaining 2 per cent on the BSE in Tuesday’s intra-day trade in an otherwise weak market after the company said it has acquired Huminsulin in India from ...

Global pharma major Lupin Limited announced the acquisition of Huminsulin in India from Eli Lilly and Company (Lilly) to further enhance its diabetes portfolio. Lupin has been marketing the Huminsulin ...

Lupin Ltd has announced the acquisition of Huminsulin in India from Eli Lilly and Company (Lilly) to further enhance its diabetes portfolio for an unspecified amount. Lupin has been marketing the ...

through existing agreements with Eli Lilly India. The Huminsulin range is a treatment option for both type 1 and type 2 diabetes, helping to regulate blood sugar levels in adults and children.